Thornberry Nancy has filed 17 insider transactions across 3 companies since May 2023.
Most recent transaction: a grant/award of 5997 shares of Schrodinger, Inc. ($SDGR) on June 18, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 18, 2025 | Schrodinger, Inc. | $SDGR | Thornberry Nancy | Director | A | Common Stock | 5997 | $0.00 | 17,247.0000 | 72,670,295 | 53.31% | 0.01% |
| June 18, 2025 | Schrodinger, Inc. | $SDGR | Thornberry Nancy | Director | A | Stock Option (right to buy) | 9341 | $0.00 | 9,341.0000 | 72,670,295 | 9999.99% | 0.01% |
| June 3, 2025 | Denali Therapeutics Inc. | $DNLI | Thornberry Nancy | Director | A | Common Stock | 6037 | $0.00 | 24,717.0000 | 164,473,772 | 32.32% | 0.00% |
| June 3, 2025 | Denali Therapeutics Inc. | $DNLI | Thornberry Nancy | Director | A | Stock Option (right to buy) | 18111 | $0.00 | 18,111.0000 | 164,473,772 | 9999.99% | 0.01% |
| May 1, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Thornberry Nancy | Director | A | Common Stock | 398 | $0.00 | 2,035.0000 | 257,899,999 | 24.31% | 0.00% |
| May 1, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Thornberry Nancy | Director | A | Stock Option (Right to Buy) | 1199 | $0.00 | 1,199.0000 | 257,899,999 | 9999.99% | 0.00% |
| June 18, 2024 | Schrodinger, Inc. | $SDGR | Thornberry Nancy | Director | A | Stock Option (right to buy) | 8550 | $0.00 | 8,550.0000 | 74,986,816 | 9999.99% | 0.01% |
| June 18, 2024 | Schrodinger, Inc. | $SDGR | Thornberry Nancy | Director | A | Common Stock | 5000 | $0.00 | 11,250.0000 | 74,986,816 | 80.00% | 0.01% |
| May 31, 2024 | Denali Therapeutics Inc. | $DNLI | Thornberry Nancy | Director | A | Common Stock | 5967 | $0.00 | 18,680.0000 | 137,370,897 | 46.94% | 0.00% |
| May 31, 2024 | Denali Therapeutics Inc. | $DNLI | Thornberry Nancy | Director | A | Stock Option (right to buy) | 17901 | $0.00 | 17,901.0000 | 137,370,897 | 9999.99% | 0.01% |
| May 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Thornberry Nancy | Director | A | Common Stock | 501 | $0.00 | 1,637.0000 | 260,500,000 | 44.10% | 0.00% |
| May 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Thornberry Nancy | Director | A | Stock Option (Right to Buy) | 1571 | $0.00 | 1,571.0000 | 260,500,000 | 9999.99% | 0.00% |
| June 15, 2023 | Schrodinger, Inc. | $SDGR | Thornberry Nancy | Director | A | Common Stock | 6250 | $0.00 | 6,250.0000 | 71,173,419 | 9999.99% | 0.01% |
| June 15, 2023 | Schrodinger, Inc. | $SDGR | Thornberry Nancy | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 71,173,419 | 9999.99% | 0.02% |
| May 22, 2023 | Schrodinger, Inc. | $SDGR | Thornberry Nancy | Director | M | Common Stock | 14850 | $11.52 | 14,850.0000 | 71,173,419 | 9999.99% | 0.02% |
| May 22, 2023 | Schrodinger, Inc. | $SDGR | Thornberry Nancy | Director | S | Common Stock | 14850 | $35.00 | 0.0000 | 71,173,419 | 100.00% | 0.02% |
| May 22, 2023 | Schrodinger, Inc. | $SDGR | Thornberry Nancy | Director | M | Stock Option (right to buy) | 14850 | $0.00 | 27,020.0000 | 71,173,419 | 35.47% | 0.02% |